Advertisement

Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Europe and Israel or involving organisations from these countries.

Total search results: 6472 | Ordered by Date (descending)
1 2 3 ... 63 64 65  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Relief Therapeutics–SEVERAL: investment, 202107 private placement CHF15m with 71.4m common stock at CHF0.21/share to two US institutional investors 2021-07-26
Abivax–SEVERAL: credit, 202107– convertible bonds €25m at 6% interest/year 2021-07-23
Abivax–SEVERAL: investment, 202107 capital increase €60m with 3% discount with 1.97m shares at €30.55/share 2021-07-23
Anocca–SEVERAL: investment, 202107 financing round Series B SEK400m ($47m) led by Danske Bank 2021-07-22
Sophia Genetics–SEVERAL: investment, 202107 US IPO $234m+$35.1m with 13m+1.95m ordinary shares at $18/Share at Nasdaq Global Select Market 2021-07-22
Coave Therapeutics–Eurazeo: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Idinvest 2021-07-21
Coave Therapeutics–eureKARE: investment, 202107 financing round Series B extension totalling €21.2m incl new + co-investor eureKARE 2021-07-21
Coave Therapeutics–Fund+: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Fund+ 2021-07-21
Coave Therapeutics–GO Capital (FR): investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor GO Capital 2021-07-21
Coave Therapeutics–Huntsworth: public relations, 202107 service existent by Medistrava Consulting 2021-07-21
Coave Therapeutics–Kurma Partners: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Kurma Partners 2021-07-21
Coave Therapeutics–Omnes Capital: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Omnes Capital 2021-07-21
Coave Therapeutics–Seroba: investment, 202107 financing round Series B extension totalling €21.2m incl lead investor Seroba Life Sciences 2021-07-21
Coave Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €21.2m bringing total Series B to €33.1m 2021-07-21
Coave Therapeutics–Sham: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor Sham Innovation Santé 2021-07-21
Coave Therapeutics–Théa Open Innovation: investment, 202107 financing round Series B extension totalling €21.2m incl new + co-investor Théa OI 2021-07-21
Coave Therapeutics–V-Bio Ventures: investment, 202107 financing round Series B extension totalling €21.2m incl existing + co-investor V-Bio Ventures 2021-07-21
Excellims–Covalent Bonds: public relations, 202107 service existent by Covalent Bonds 2021-07-21
3a-Diagnostics–XPhyto Therapeutics: investment, 202107– 202110 acqisition 100% €400k upfront + €3.5m at closing ANNOUNCED 2021-07-20
Panakès Partners–EU (govt): investment, 202107 first closing totalling €150m of Purple Fund incl co-lead investor EIF 2021-07-20
Panakès Partners–Italy (govt): investment, 202107 first closing totalling €150m of Purple Fund incl co-lead investor CDP Venture Capital FoF 2021-07-20
Panakès Partners–SEVERAL: investment, 202107 first closing €150m of Purple Fund 2021-07-20
Intelligent Tissue Group–BioIVT: investment, 202107 acquisition €na of Tissue Solutions Ltd by BioIVT 2021-07-19
Dopavision–Akampion: public relations, 202107 service existent by Akampion 2021-07-14
Dopavision–Boehringer: investment, 202107 financing round Series A totalling €12m incl existing + co-investor BIVF 2021-07-14
Dopavision–BPCE: investment, 202107 financing round Series A totalling €12m incl new + lead investor Seventure Partners 2021-07-14
Dopavision–Eternity.Health: investment, 202107 financing round Series A totalling €12m incl existing + co-investor Ababax Health 2021-07-14
Dopavision–Novartis: investment, 202107 financing round Series A totalling €12m incl new + co-investor Novartis Pharmaceuticals 2021-07-14
Dopavision–SEVERAL: investment, 202107 financing round Series A €12m led by new investor Seventure Partners 2021-07-14
Immunic–SEVERAL: investment, 202107 underwritten public offering $45m with 4.5m shares common stock at $10/share 2021-07-14
Kriya Therapeutics–SEVERAL: investment, 202107 financing round Series B $100m led by Patient Square Capital + incl new + existing investors 2021-07-14
Mobilion–SEVERAL: investment, 202107 financing round Series C $60m led by new investor D1 Capital Partners 2021-07-13
Vectura–Philip Morris: investment, 202107– acquisition recommended cash tender offer GBP852m at150p/share 2021-07-09
Exscientia–Gates Foundation: grant, 202107– grant $1.5m for AI-based design of Mpro inhibitors for COVID-19 from GF + Gates Philanthropy Partners 2021-07-08
Micropep Technologies–CEA Industrie: investment, 202107 financing round Series A totalling €8.5m incl new + lead investor Supernova Invest 2021-07-08
Micropep Technologies–FMC: investment, 202107 financing round Series A totalling €8.5m incl new + co-investor FMC Ventures 2021-07-08
Micropep Technologies–IRDI Soridec: investment, 202107 financing round Series A totalling €8.5m incl existing + co-investor IRDI Capital 2021-07-08
Micropep Technologies–SEVERAL: investment, 202107 financing round Series A €8.5m led by Supernova Invest 2021-07-08
Micropep Technologies–Sofinnova: investment, 202107 financing round Series A totalling €8.5m incl existing + co-investor Sofinnova Partners 2021-07-08
Theolytics–Merck (DE): investment, 202107 financing round Series A expansion incl new investor M Ventures 2021-07-08
Theolytics–Otsuka: investment, 202107 financing round Series A expansion incl existing investor Taiho Ventures 2021-07-08
Theolytics–SEVERAL: investment, 202107 financing round Series A expansion incl new investor M Ventures 2021-07-08
Theolytics–Univ Oxford: investment, 202107 financing round Series A expansion incl existing investor Univ Oxford 2021-07-08
Nerre Therapeutics–Advent Venture Partners: investment, 202107 financing round Series B2 totalling £20m incl existing + co-investor Advent LS 2021-07-07
Nerre Therapeutics–Columbus Venture Partners: investment, 202107 financing round Series B2 totalling £20m incl new + lead investor Columbus VP 2021-07-07
Nerre Therapeutics–Consilium: public relations, 202107 service existent by Consilium Strategic Communications 2021-07-07
Nerre Therapeutics–Forbion: investment, 202107 financing round Series B2 totalling £20m incl existing + co-investor Forbion Capital Partners 2021-07-07
Nerre Therapeutics–Fountain Healthcare Partners: investment, 202107 financing round Series B2 totalling £20m incl existing + co-investor Fountain HP 2021-07-07
Nerre Therapeutics–OrbiMed: investment, 202107 financing round Series B2 totalling £20m incl existing + co-investor OrbiMed 2021-07-07
Nerre Therapeutics–SEVERAL: investment, 202107 financing round Series B2 £20m led by Columbus Venture Partners 2021-07-07
Nerre Therapeutics–United Kingdom (govt): investment, 202107 financing round Series B2 totalling £20m incl existing + co-investor UK Future Fund 2021-07-07
Cutanos–High-Tech Gründerfonds: investment, 202107 1st financing round incl investor HTGF 2021-07-05
Cutanos–IST Cube: investment, 202107 1st financing round incl investor IST Cube 2021-07-05
Cutanos–Khanu Management: investment, 202107 1st financing round incl investor KHAN Technology Transfer Fund I 2021-07-05
Cutanos–OTHER: investment, 202107 1st financing round incl a private investor 2021-07-05
Cutanos–SEVERAL: investment, 202107 1st financing round with KHAN-I + HTGF + IST Cube + another private investor 2021-07-05
CellGenix–Sartorius: investment, 202107 acquisition 51% share for €100m cash by SSB with planned acquisition of remaining shares until 2026 2021-07-02
Fertin Pharma–Philip Morris: investment, 202107– acquisition DKK5.1b ($820m) from EQT + Bagger-Sørensen ANNOUNCED 2021-07-01
GeneWerk–Ampersand: investment, 202107 investment existent GeneWerk GmbH is portfolio company of Ampersand 2021-07-01
Nestlé–Seres Therapeutics: microbiome-based drug, 202107– license North America $175m upfront + $350m milestones + 50% of commercial profits 2021-07-01
Zukunftsfonds Heilbronn–Ampersand: investment, 202107 acquisition of majority share in PPS from ZFHN and merger with portfolio company GeneWerk 2021-07-01
Promethera–SEVERAL: investment, 202106– financing round €20m incl €10m from Shang Ying Intl Holdings Ltd (HK) 2021-06-30
Orbit Discovery–Zyme Communications: public relations, 202106 service existent by Zyme 2021-06-29
United Kingdom (govt)–Univ Edinburgh: CAGT manufacturing, 202106– collab establishment of CGT Catapult Edinburgh at EdinBurgh BioQuarter 2021-06-29
BMS–WPP: public releations, 202106c supply service BMS is among largest + long-term health clients of Ogilvy Health 2021-06-28
Boehringer–WPP: public releations, 202106c supply service Boehringer is among largest + long-term health clients of Ogilvy Health 2021-06-28
Merck (US)–WPP: public releations, 202106c supply service Merck is among largest + long-term health clients of Ogilvy Health 2021-06-28
Pfizer–WPP: public releations, 202106c supply service Pfizer is among largest + long-term health clients of Ogilvy Health 2021-06-28
Polyphor–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media + IR contact for Polyphor 2021-06-28
Discover Echo–Cellink: investment, 202106– acquisition $110m with $98m in cash + $12m in new Series B shares ANNOUNCED 2021-06-26
Pixium Vision–LifeSci: public relations, 202106 supply service existent LifeSci Advisors is media + IR contact for Pixium Vision 2021-06-25
EQRx–Exscientia: AI-based drug discovery, 202106– strategic collab r+d + commerc with equally shared costs 2021-06-24
Merck (DE)–Nucleai MD: AI-based biomarker discovery, 202106– long-term collab using ATOM platform for cancer biomarker discovery 2021-06-24
RheinCell Therapeutics–Catalent: investment, 202106– acquisition of RheinCell by Catalent ANNOUNCED 2021-06-24
Cambridge Cancer Genomics–Dante Labs: investment, 202106 acquisition of CCG.ai by Dante Labs 2021-06-23
FundaMental Pharma–High-Tech Gründerfonds: investment, 202106 seed funding from HTGF 2021-06-23
Leukocare–Petrichor Healthcare: credit, 202106– convertible loan totalling $15m incl Petrichor HCM 2021-06-23
Leukocare–Petrichor Healthcare: investment, 202106 equity investment $2.5m from Petrichor HCM 2021-06-23
Leukocare–SEVERAL: credit, 202106– convertible loan $15m led by Petrichor HCM + incl existing shareholders 2021-06-23
Monte Rosa Therapeutics–SEVERAL: investment, 202106 IPO $222.3m+$33.345m with 11.7m+1.755m shares common stock at Nasdaq Global Select Market 2021-06-23
Paramit–Tecan: investment, 202106– acquisition $1b from Altaris Capital Partners LLC ANNOUNCED 2021-06-23
908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool 2021-06-22
908 Devices–Securecell: bioprocess control technology, 202106 collab product integration Rebel media analyzer with Lucullus PIMS 2021-06-22
Corlieve Therapeutics–Uniqure: investment, 202106– acquisition €46.3m upfront cash + €203.7m milestones ANNOUNCED 2021-06-22
Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED 2021-06-22
Owler–Meltwater: investment, 202106– acquisition $24.5m with $18.9m in cash + $5.6m in equity ANNOUNCED 2021-06-18
Aldevron–Danaher: investment, 202106– acquisition $9.6b in cash by Danaher ANNOUNCED 2021-06-17
Apollo Therapeutics Fund–SEVERAL: investment, 202106 financing round $145m led by Patient Square Capital taking controlling equity position 2021-06-17
Chemic Laboratories–Solvias: investment, 202106 acquisition €na by Solvias 2021-06-17
Kahr-Medical–aMoon: investment, 202106 financing round totalling $46.5m incl lead investor aMoon 2021-06-16
Kahr-Medical–BVF Partners: investment, 202106 financing round totalling $46.5m incl new + co-investor BVF Partners LP 2021-06-16
Kahr-Medical–Cancer Focus Fund: investment, 202106 financing round totalling $46.5m incl new + co-investor Cancer Focus Fund 2021-06-16
Kahr-Medical–Dafna Capital: investment, 202106 financing round totalling $46.5m incl new + co-investor Dafna Capital Management LLC 2021-06-16
Kahr-Medical–Flerie Invest: investment, 202106 financing round totalling $46.5m incl existing + co-investor Flerie Invest AB 2021-06-16
Kahr-Medical–Hadasit Bio-Holdings: investment, 202106 financing round totalling $46.5m incl existing + co-investor Hadasit Bio Holdings Ltd 2021-06-16
Kahr-Medical–Mirae Asset: investment, 202106 financing round totalling $46.5m incl existing + co-investor Mirae Asset 2021-06-16
Kahr-Medical–Oriella: investment, 202106 financing round totalling $46.5m incl existing + co-investor Oriella Ltd 2021-06-16
Kahr-Medical–Pavilion Capital: investment, 202106 financing round totalling $46.5m incl existing + co-investor Pavilion Capital 2021-06-16
Kahr-Medical–Peregrine Ventures: investment, 202106 financing round totalling $46.5m incl new + co-investor Peregrine Ventures 2021-06-16
Kahr-Medical–SEVERAL: investment, 202106 financing round $46.5m led by aMoon 2021-06-16
1 2 3 ... 63 64 65  next pagenext page



Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

» top